Company / Current Assets per Share
NOVAVAX INC Current Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$6.10
FY2025
5-year range
$6.10 / $30.37
FY2021-FY2025
Trend
-24.6%
vs FY2024
Sector context
#119 of 210
Health Care
What the data says
At $6.10, NOVAVAX INC's current assets per share ranks #119 of 210 in the Health Care sector. Current Assets per Share has declined for 5 consecutive years, from $38.58 in FY2020 to $6.10 in FY2025.
Based on SEC 10-K filings.
6.10 in FY2025 with a 5-year CAGR of -30.9%.
Declined from $13.29 to $6.10 over the past 2 years.
Health Care sector context is included.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- -35.2%
- 5-Year CAGR
- -30.9%
- 10-Year CAGR
- -
Sector benchmark
#119 of 210 in Health CareTop 57% of 210This company $6.10 Sector average $134.38
▼
-95.5% below sector average
Key checks
Key Insights
- NOVAVAX INC's current assets per share has declined for 5 consecutive years.
- In FY2025, current assets per share decreased 24.6% year-over-year.
- Ranks #119 out of 210 companies in the Health Care sector.
- Peak current assets per share was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score -0.87 (distress zone, below 1.8 threshold)
- Negative profit margin: -27.5%
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $6.10 | -24.6% |
| FY2024 | $8.09 | -39.1% |
| FY2023 | $13.29 | -40.8% |
| FY2022 | $22.46 | -26.1% |
| FY2021 | $30.37 | -21.3% |
| FY2020 | $38.58 | +662.6% |
| FY2019 | $5.06 | +1271.0% |
| FY2018 | $0.37 | -50.8% |
| FY2017 | $0.75 | -29.7% |
| FY2016 | $1.07 | -11.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026